10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2016 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 14, 2017) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Revenues: | |||
| Product sales | $ 21,892 | 20,944 | 19,327 |
| Other revenues | 1,099 | 718 | 736 |
| Total revenues | 22,991 | 21,662 | 20,063 |
| Operating expenses: | |||
| Cost of sales | 4,162 | 4,227 | 4,422 |
| Research and development | 3,840 | 4,070 | 4,297 |
| Selling, general and administrative | 5,062 | 4,846 | 4,699 |
| Other | 133 | 49 | 454 |
| Total operating expenses | 13,197 | 13,192 | 13,872 |
| Operating income | 9,794 | 8,470 | 6,191 |
| Interest expense, net | 1,260 | 1,095 | 1,071 |
| Interest and other income, net | 629 | 603 | 465 |
| Income before income taxes | 9,163 | 7,978 | 5,585 |
| Provision for income taxes | 1,441 | 1,039 | 427 |
| Net income | 7,722 | 6,939 | 5,158 |
| Earnings per share: | |||
| Basic (in usd per share) | 10.32 | 9.15 | 6.80 |
| Diluted (in usd per share) | 10.24 | 9.06 | 6.70 |
| Shares used in the calculation of earnings per share: | |||
| Basic (in shares) | 748 | 758 | 759 |
| Diluted (in shares) | 754 | 766 | 770 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2016 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 14, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Net income | $ 7,722 | 6,939 | 5,158 |
| Other comprehensive income (loss), net of reclassification adjustments and taxes: | |||
| Foreign currency translation losses | (99) | (247) | (196) |
| Effective portion of cash flow hedges | (15) | 7 | 323 |
| Net unrealized gains (losses) on available-for-sale securities | 122 | (241) | 24 |
| Other | 1 | 9 | 2 |
| Other comprehensive income (loss), net of tax | 9 | (472) | 153 |
| Comprehensive income | 7,731 | 6,467 | 5,311 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2016 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 14, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Cash flows from operating activities: | |||
| Net income | $ 7,722 | 6,939 | 5,158 |
| Depreciation and amortization | 2,105 | 2,108 | 2,092 |
| Stock-based compensation expense | 311 | 322 | 408 |
| Deferred income taxes | 183 | (607) | (108) |
| Other items, net | 32 | (146) | 56 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (214) | (420) | 136 |
| Inventories | (80) | 481 | 327 |
| Other assets | (128) | 155 | (1) |
| Accounts payable | (44) | (12) | 228 |
| Accrued income taxes | (301) | 509 | (103) |
| Other liabilities | 768 | 402 | 759 |
| Net cash provided by operating activities | 10,354 | 9,731 | 8,952 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (738) | (594) | (718) |
| Cash paid for acquisitions, net of cash acquired | 0 | (359) | (165) |
| Purchases of intangible assets | (99) | (55) | (285) |
| Purchases of marketable securities | (28,094) | (25,977) | (25,878) |
| Proceeds from sales of marketable securities | 17,958 | 18,029 | 16,697 |
| Proceeds from maturities of marketable securities | 2,459 | 3,527 | 4,199 |
| Proceeds from sale of property, plant and equipment | 78 | 274 | 3 |
| Change in restricted investments, net | 0 | 0 | 533 |
| Other | (222) | (392) | (138) |
| Net cash used in investing activities | (8,658) | (5,547) | (5,752) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 7,318 | 3,465 | 4,476 |
| Repayment of debt | (3,725) | (2,400) | (5,605) |
| Repurchases of common stock | (2,965) | (1,867) | (138) |
| Dividends paid | (2,998) | (2,396) | (1,851) |
| Net proceeds from issuance of common stock in connection with the Companys equity award programs | 55 | 82 | 186 |
| Settlement of contingent consideration obligations | 0 | (253) | (92) |
| Withholding taxes arising from shares withheld for share-based payments | (260) | (401) | (225) |
| Other | (24) | (1) | (25) |
| Net cash used in financing activities | (2,599) | (3,771) | (3,274) |
| (Decrease) increase in cash and cash equivalents | (903) | 413 | (74) |
| Cash and cash equivalents at beginning of period | 4,144 | 3,731 | |
| Cash and cash equivalents at end of period | 3,241 | 4,144 | 3,731 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2016 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2016 10-K (Filed: Feb 14, 2017) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2016 | Dec 31, 2015 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 3,241 | 4,144 |
| Marketable securities | 34,844 | 27,238 |
| Trade receivables, net | 3,165 | 2,995 |
| Inventories | 2,745 | 2,435 |
| Other current assets | 2,015 | 1,703 |
| Total current assets | 46,010 | 38,515 |
| Property, plant and equipment, net | 4,961 | 4,907 |
| Intangible assets, net | 10,279 | 11,641 |
| Goodwill | 14,751 | 14,787 |
| Other assets | 1,625 | 1,599 |
| Total assets | 77,626 | 71,449 |
| LIABILITIES AND STOCKHOLDERS EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 917 | 965 |
| Accrued liabilities | 5,884 | 5,452 |
| Current portion of long-term debt | 4,403 | 2,247 |
| Total current liabilities | 11,204 | 8,664 |
| Long-term debt | 30,193 | 29,182 |
| Long-term deferred tax liability | 2,436 | 2,239 |
| Long-term tax liabilities | 2,419 | 1,973 |
| Other noncurrent liabilities | 1,499 | 1,308 |
| Contingencies and commitments | ||
| Stockholders equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding 738.2 shares in 2016 and 754.0 shares in 2015 | 30,784 | 30,649 |
| Accumulated deficit | (438) | (2,086) |
| Accumulated other comprehensive loss | (471) | (480) |
| Total stockholders equity | 29,875 | 28,083 |
| Total liabilities and stockholders equity | 77,626 | 71,449 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |